Faecal microbiota transplantation in patients with irritable bowel syndrome modulates the gut microbiome but lacks clinical effects: results of a randomised, double-blind crossover clinical trial
在一项涉及肠易激综合征患者的随机、双盲、交叉临床试验中,粪便微生物移植成功改变了肠道微生物群组成,但未能产生任何显著的症状严重程度改善。